Deconstructing tumor heterogeneity: the stromal perspective

Renee E Vickman1,2, Douglas V Faget3,2, Philip Beachy4

  • 1Department of Surgery, NorthShore University HealthSystem, Evanston, IL, USA.

Oncotarget
|October 22, 2020
PubMed

Insights

Non-immune stromal cells critically regulate tumor heterogeneity, impacting growth and therapy resistance. Understanding these stromal elements is key to identifying new cancer treatment strategies.

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment

Background:

  • Immune cells' role in tumor progression is known, but non-immune stromal components remain poorly understood.
  • Stromal elements significantly influence tumor heterogeneity, initiation, progression, and therapeutic resistance.

Purpose of the Study:

  • To highlight and integrate the functions of non-immune stromal components in regulating tumor heterogeneity.
  • To explore the dual roles of tumor-supportive versus tumor-suppressive stroma.
  • To identify challenges and knowledge gaps regarding the tumor microenvironment.

Main Methods:

  • NCI-sponsored workshop integrating diverse research perspectives.
  • Discussions on cellular composition, function, and spatial geography of the tumor microenvironment.
  • Exploration of prognostic and therapeutic implications of stromal elements.

Main Results:

  • Non-immune stromal components critically regulate tumor heterogeneity.
  • Stromal composition and function can change during disease progression, influencing tumor behavior.
  • Microenvironment and spatial factors dictate lesion aggressiveness and therapeutic response.

Conclusions:

  • Further research is needed to define the roles of non-immune stromal cells in cancer.
  • Understanding the tumor microenvironment is crucial for developing effective cancer therapies.
  • Identifying vulnerabilities within the heterogeneous tumor microenvironment presents therapeutic opportunities.